← Back to Clinical Trials
RecruitingNCT06224205

Digital Detection of Dementia (D Cubed) Studies: D3

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionAlzheimer Disease and Related Dementias (ADRD)
SponsorIndiana University
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment3,150
SexALL
Min Age65 Years
Max AgeN/A
Start Date2023-11-08
Completion2025-11-08
Interventions
Passive Digital Marker for screening for ADRD

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The specific aim of the pragmatic trial is to evaluate the practical utility and effect of the PDM, the QDRS, and the combined approach (PDM + QDRS) in improving the annual rate of new documented ADRD diagnosis in primary care practices.

Eligibility Criteria

Inclusion Criteria: * 65 years or older * At least one visit to primary care practice within the past year * Ability to provide informed consent * Ability to communicate in English or Spanish * Available EHR data from at least the past three years Exclusion Criteria: * Prior ADRD or mild cognitive impairment diagnosis as determined by ICD-10 code * Evidence of any history of prescription for a cholinesterase inhibitors or memantine. * Has serious mental illness such as bipolar or schizophrenia as determined by ICD-10 code * Permanent resident of a nursing facility

Related Trials